Many Breast Cancer Survivors Don't Get Life-Extending Therapy

Many Breast Cancer Survivors Don’t Get Life-Extending Therapy

CLICK HERE FOR FULL ARTICLE FROM Health Day

Hormonal therapies such as tamoxifen, or a class of drugs called aromatase inhibitors, can reduce the likelihood that women diagnosed with certain breast cancers will experience a recurrence of their disease. However, a new study finds these treatments — used in breast cancers that are responsive to hormones such as estrogen — are too seldom utilized or often used incorrectly.  According to the research team, if all U.S. breast cancer survivors who needed them followed recommendations for hormone therapy, that could mean almost 15,000 lives saved over a decade.  Unfortunately, these drugs are “still underused, and in some cases, misused — offered to patients who lack [estrogen] hormone receptors” on their tumor cells, explained study senior author Dr. Dezheng Huo.  He’s associate professor of public health sciences at the University of Chicago.  Source:  HealthDay, February 2, 2017

×

Upcoming Events

Attending any of these upcoming events? Have other events to share? Let us know! Email us at NNN@ITCMI.ORG to share your event information or to get on our list serve for event updates.

 

WEBINAR -- "Business or Exploitation?"  Exposure of the tobacco industry's exploitation of individuals with mental health conditions -- Thursday, January 18, 2018, 1 p.m. EST (60 minutes) - Brought to you by the Smoking Cessation Leadership Center, National Behavioral Health Network for Tobacco and Cancer Control, and Truth Initiative® -- Presenters:  Margaret Jaco Manecke, MSSW, Project Manager, Practice Improvement, National Council for Behavioral Health; Ashley Persie, Senior Brand Marketing Associate, Truth Initiative®; Judith (Jodi) Prochaska, PhD, MPH, Associate Professor of medicine, Stanford University -- Webinar Objectives:  1.  Explain why people with mental health conditions (depression and ADHD, for example) and substance use disorders have been historically targeted by the tobacco industry.  2.  State whether adults with mental health conditions and substance use disorders smoke more than adults without those conditions.  3.  Describe the morbidity rates of people with mental health conditions and name specific causes of death that can be attributed to tobacco use.  4.  Explain the impact of the truth® campaign among its target audience.  5.  Describe evidence-based approaches for treating tobacco use and tobacco addiction in persons with co-occurring mental illness.  6.  Describe how you can leverage the National Behavioral Health Network for Tobacco & Cancer Control's tools, resources, and network to combat tobacco use & cancer disparities among individuals with mental illnesses and addictions and network members.  REGISTER HERE | DOWNLOAD FUNDING ANNOUNCEMENT HERE

It's About a Billion Lives Symposium -- February 2, 2018, 8:30 a.m. - 12:30 p.m. - University of California San Francisco, San Francisco, CA - SAVE THE DATE - LEARN MORE

EVENT -Dialogue for Action® - April 11-13, 2018; Hilton McLean Tysons Corner; McLean, VirginiaDialogue for Action® is an annual national conference that brings a diversity of stakeholders together to discuss the best ways to reinforce cancer screening, prevention, and risk reduction initiatives in their communities.  The Wednesday through Friday schedule is packed with unique opportunities for participants to immerse themselves in engaging presentations facilitated conversations, relationship building, and more.  LEARN MORE

Funding Opportunity - Robert Wood Johnson Foundation - Policies for Action:  Policy and Law Research to Build a Culture of Health - HERE